Related Experiment Video
Updated: Mar 16, 2026

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Does asymptomatic recurrent diffuse capillary C4d complement deposition impair cardiac allograft function?
Simone Frea1, Cristina Iacovino2, Michela Botta2
1Division of Cardiology, Internal Medicine Department, Città della Salute e della Scienza and University of Torino, Torino, Italy. simone.frea@libero.it.
Insights
Recurrent antibody-mediated rejection (AMR) in heart transplant patients, even without clear biopsy signs, can lead to adverse graft remodeling and impaired left ventricular function within the first year. Early detection of diffuse capillary C4d immunostaining is crucial.
Area of Science:
- Cardiology
- Transplantation Immunology
- Cardiac Pathology
Background:
- Antibody-mediated rejection (AMR) is a significant concern after heart transplantation.
- Asymptomatic recurrent AMR (rAMR), defined by diffuse capillary C4d immunostaining on endomyocardial biopsies (EMBs), requires further investigation for its impact on graft function.
- Left ventricular (LV) function and remodeling are key indicators of cardiac allograft health.
Purpose of the Study:
- To evaluate the impact of asymptomatic rAMR on LV function and remodeling in the first year post-heart transplantation.
- To determine if diffuse capillary C4d immunostaining (rAMR) is an early marker for graft dysfunction.
- To assess the risk of LV dysfunction and adverse remodeling associated with rAMR.
Main Methods:
- Prospective study of 54 heart transplant recipients with stable graft function one month post-transplant.
- Regular echocardiography (490 total) and endomyocardial biopsies (EMBs) were performed during the first year.
- Asymptomatic rAMR (diffuse capillary C4d immunostaining) was analyzed as a risk factor for graft deterioration.
Main Results:
- Five patients developed rAMR within the first year.
- rAMR was significantly associated with increased risk of LV concentric hypertrophy (OR 3.6) and reduced lateral S' peak velocity (OR 2.3).
- Patients with rAMR exhibited adverse graft remodeling (increased LV end-diastolic volume) and functional deterioration (reduced lateral S' peak velocity).
Conclusions:
- Recurrent asymptomatic diffuse capillary C4d immunostaining is linked to early adverse cardiac allograft remodeling.
- rAMR may contribute to the development of graft dysfunction after heart transplantation.
- Monitoring for C4d deposition is important for identifying early signs of rejection and preserving graft function.
Background:
The aim of this study was to evaluate whether asymptomatic recurrent (≥2) antibody-mediated rejection (pAMR 1+), defined as diffuse capillary C4d immunostaining (rAMR) on endomyocardial biopsies (EMBs), during the first year after heart transplantation impairs left ventricular (LV) function.
Methods:
Fifty-four consecutive heart transplant patients who survived well (New York Heart Association ≤2 and EF≥55%) the first month after transplantation were enrolled and prospectively underwent 490 echocardiographies and EMB. Asymptomatic rAMR without histopathologic findings was evaluated as a risk factor for deterioration of graft function. Primary endpoint, assessed 1 year after transplantation, was development of LV dysfunction and/or adverse remodeling according to pre-specified echo parameters.
Results:
During the first year from transplantation, rAMR occurred in five patients. Recurrent AMR was associated with a significant higher risk to develop LV concentric hypertrophy (OR 3.6, 95% CI: 1.8-7.0, P=.02) or reduced lateral S' peak velocity (OR 2.3, 95% CI: 1.5-3.6, P=.03). Patients with rAMR showed significative adverse graft remodeling (ΔLV end-diastolic volume: +16±12.3 vs -0.2±14.4 mL; P=.02) and deterioration of graft function (Δlateral S' peak velocity: -3.3±3 vs -0.4±2.9 cm/s; P=.03).
Conclusions:
Recurrent asymptomatic diffuse capillary C4d immunostaining may play a role in the early development of cardiac allograft adverse remodeling and dysfunction.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Cardiomyopathy V: Interprofessional Care

